£100.00

Oxford University Press Antisense Technology in the Central Nervous System

Price data checked 2 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£100 today · previous high £100 · all-time low £92

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days • 89 data points

Historical
Generating forecast...
£100.00 £91.64 £93.46 £95.29 £97.11 £98.94 £100.76 19 February 2026 13 March 2026 04 April 2026 26 April 2026 18 May 2026

Price Distribution

Price distribution over 89 days • 2 price levels

Days at Price
Current Price
86 days 3 days · current 0 22 43 65 86 £92 £100 Days at Price

Price Analysis

Most common price: £92 (86 days, 96.6%)

Price range: £92 - £100

Price levels: 2 different prices over 89 days

Description

Antisense technology has been used for several years to "knock down" the expression of specific genes in living tissues to study the functions of their protein products. Specifically designed antisense oligonucleotides (ODNs) are short lengths of man-made genetic material designed to interfere with the production of the protein encoded by the gene. This can shed light on the function of the protein; alternatively, if a disease process results from an excess of a certain protein, the method can in theory correct the problem. Faster than transgenic techniques, but more similarly problematic in practice, antisense has been seen as something of a "black art". There are many technical problems to understand and overcome. This is the first book to provide a critical review of the uses of this technology in the central nervous system. Antisense Technology in the Central Nervous System describes the promises and the pitfalls of this approach, and compares it to other approaches. The practical experience of leading researchers is combined with a thorough description of the theoretical foundation of the technique, making the book ideal for researchers and clinicians alike.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
14 October 1999
Listed Since
15 December 2006

Barcode

No barcode data available

Similar Products You Might Like

RNA Interference Techniques: 58 (Neuromethods, 58)
78% match

RNA Interference Techniques: 58 (Neuromethods, 58)

Humana

£71.93 04 May 2026
Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)
76% match

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Humana

£121.64 18 May 2026
Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)
76% match

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Humana

£73.10 18 May 2026
Apoptosis Techniques and Protocols: 37 (Neuromethods, 37)
76% match

Apoptosis Techniques and Protocols: 37 (Neuromethods, 37)

Humana

£73.85 18 May 2026
76% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 20 May 2026
RNA Interference and CRISPR Technologies: Technical Advances and New Therapeutic Opportunities: 2115 (Methods in Molecular Biology, 2115)
76% match

RNA Interference and CRISPR Technologies: Technical Advances and New Therapeutic Opportunities: 2115 (Methods in Molecular Biology, 2115)

Humana

£111.46 11 May 2026
Neural Stem Cells: Methods and Protocols: 438 (Methods in Molecular Biology, 438)
76% match

Neural Stem Cells: Methods and Protocols: 438 (Methods in Molecular Biology, 438)

Humana

£88.17 20 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
76% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.11 18 May 2026
Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules (Medical Intelligence Unit)
76% match

Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules (Medical Intelligence Unit)

Springer

£107.98 18 May 2026
DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases (RNA Technologies)
76% match

DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases (RNA Technologies)

Springer

£113.94 11 May 2026
Molecular Neurobiological Techniques: 16 (Neuromethods, 16)
75% match

Molecular Neurobiological Techniques: 16 (Neuromethods, 16)

Humana

£47.47 16 May 2026
Techniques to Investigate Mitochondrial Function in Neurons: 123 (Neuromethods, 123)
75% match

Techniques to Investigate Mitochondrial Function in Neurons: 123 (Neuromethods, 123)

Humana

£95.70 18 May 2026
Neurogenetic Diagnoses: The Power of Hope and the Limits of Today’s Medicine (Genetics and Society)
75% match

Neurogenetic Diagnoses: The Power of Hope and the Limits of Today’s Medicine (Genetics and Society)

Routledge

£140.33 18 May 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
75% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 18 May 2026
In Vivo Neuromethods: 32
75% match

In Vivo Neuromethods: 32

Humana

£75.90 18 May 2026
Molecular Neurobiological Techniques: 16 (Neuromethods, 16)
75% match

Molecular Neurobiological Techniques: 16 (Neuromethods, 16)

Humana

£104.31 16 May 2026
Stem Cells and CNS Development (Contemporary Neuroscience)
75% match

Stem Cells and CNS Development (Contemporary Neuroscience)

Humana

£107.98 18 May 2026
75% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Academic Press

£157.99 20 May 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
75% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£50.21 20 May 2026
RNA Technologies and Their Applications
75% match

RNA Technologies and Their Applications

Springer

£149.30 11 May 2026
Protocols in Molecular Neurobiology: 13 (Methods in Molecular Biology, 13)
74% match

Protocols in Molecular Neurobiology: 13 (Methods in Molecular Biology, 13)

Humana

£76.05 18 May 2026
Stimulation and Inhibition of Neurons: 78 (Neuromethods, 78)
74% match

Stimulation and Inhibition of Neurons: 78 (Neuromethods, 78)

Humana

£80.64 18 May 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
74% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 18 May 2026
Neuroacanthocytosis Syndromes
74% match

Neuroacanthocytosis Syndromes

Springer

£107.72 20 May 2026